NNBP OTC
Nanobac Pharmaceuticals, Incorporated
1W: +0.0%
1M: +9900.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -85.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$911K
+64.8% ▲
Capital Expenditures
$2K
+88.0% ▲
Free Cash Flow
-$912K
+64.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$36K
-216.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2003 | FY2004 | FY2005 | FY2006 | FY2007 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$8M | -$4M | -$5M | -$7M |
| Depreciation & Amort. | $181K | $717K | $760K | $541K | $460K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $579K | $961K | -$236K | $339K | $2M |
| Other Non-Cash Items | $0 | $0 | $0 | $1M | $3M |
| Operating Cash Flow | -$2M | -$3M | -$2M | -$3M | -$911K |
| — Investing Activities — | |||||
| Capital Expenditures | -$18K | -$37K | -$41K | -$13K | -$2K |
| Acquisitions (Net) | -$81K | -$901 | $0 | $0 | $0 |
| Investment Purchases | -$3K | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $300K | $202K | $0 | -$3K | $50K |
| Investing Cash Flow | $198K | $165K | -$41K | -$15K | $49K |
| — Financing Activities — | |||||
| Net Debt Issuance | $1M | $2M | $2M | $3M | $911K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | -$36K | $0 | $0 |
| Financing Cash Flow | $2M | $3M | $2M | $3M | $911K |
| Net Change in Cash | $50K | -$32K | -$9K | $31K | -$36K |
| Cash End of Period | $50K | $18K | $9K | $40K | $4K |
| Free Cash Flow | -$2M | -$3M | -$2M | -$3M | -$912K |